Dr Tanya Mulcahy, Director of Health Innovation Hub Ireland (HIHI) and founder of Ireland’s first FemTech Ecosystem will speak at this year’s Future Health Summit as part of the innovation discussion. Tanya has over 30 years’ experience in the start-up, pharma, product development and research industry in Ireland and the US. She has a PhD in Cancer Genetics, has conducted postdoctoral research in neuropsychiatric genetics, has a BSc in Biochemistry and a Postgraduate Diploma in Clinical Trials. She has been appointed by the Minister for Health to the HPRA Medical Device Advisory Committee. She is an Advisory Committee member of the National Clinical Trials Office (NCTO). She is an independent advisor to a number of HealthTech start-ups. Tanya is an advocate for female founders and is particularly interested in supporting FemTech founders.

The summit will feature the importance of innovation. Healthcare innovation comes in many forms, from breakthrough drugs and devices that can change outcomes on a global level, to small changes in specific settings that improve productivity, efficiency and patient experience. The session will focus on  innovations that are driving change for the better.

The line up for the session on Thursday 25th May is as follows:
Session Chair | Conference Chair

14:40 – 14:55

Prof Colin Doherty, consultant neurologist and director of the epilepsy service at St James’s Hospital. Head of School of Medicine, TCD and Clinical lead SFI FutureNeuro Centre.

14:55 – 15:10

Anne O’Connor, Managing Director, VHI Health and Wellbeing

15:10 – 15:25

Dr Tanya Mulcahy, Director, Health Innovation Hub Ireland (HIHI)

Innovation in Women’s Health- Ireland’s FemTech Ecosystem. 

15:25 – 15:40

Brent Burns, Executive Vice President, UPMC Enterprises

15:40 – 16:00 | Panel discussion chaired by conference chair

She has over 30 years’ experience in the start-up, pharma, product development and research industry in Ireland and the US. She has a PhD in Cancer Genetics, has conducted postdoctoral research in neuropsychiatric genetics, has a BSc in Biochemistry and a Postgraduate Diploma in Clinical Trials.
She has been appointed by the Minister for Health to the HPRA Medical Device Advisory Committee. She is an Advisory Committee member of the National Clinical Trials Office (NCTO). She is an independent advisor to a number of HealthTech start-ups. Tanya is an advocate for female founders and is particularly interested in supporting FemTech founders.

For more details visit https://www.futurehealthsummit.com/